Cramer Refutes the Sell Rating on Ceradyne (CRDN)

Print Email

Cramer interviewed Joel Moskowitz, CEO of Ceradyne (CRDN), to end MAD MONEY on CNBC tonight.  Cramer said that the recent SELL rating from FBR on concerns of a potential demand cut from body armor causing a $9 drop recently is not right and they shouldn’t be scared.  The CEO said they have more 2007 body armor orders than they have ever had.  He said the US in 2007 and 2008 are indicating that they want to maintain high body armor levels in what may be for all field personnel, but that is from discussions rather than firm orders.  They have an 80,000 square foot facility they opened for the armor for trucks and they have $250 million in quotes that are pending on the table.  Cramer said that he is going with the bull case and he thinks the FBR research call for a Sell on the stock is Wrong.

Jon C. Ogg
January 22, 2007

RSS Facebook Twitter